volunteer exclusion [Study Per­for­mance]

posted by Dr_Dan  – 2016-02-16 14:12  – Posting: # 15997
Views: 4,963

Dear Yura
Ideally, all treated subjects should be included in the statistical analysis. However, subjects in a crossover trial who do not provide evaluable data for both of the test and reference products (or who fail to provide evaluable data for the single period in a parallel group trial) should not be included. In principle any reason for exclusion of a subject from statistical evaluation is valid provided it is specified in the protocol and the decision to exclude is made before bioanalysis. Exclusion of data cannot be accepted on the basis of statistical analysis or for pharmacokinetic reasons alone, because it is impossible to distinguish the formulation effects from other effects influencing the pharmacokinetics.
I hope this helps.
Kind regards

Kind regards and have a nice day

Complete thread:

 Admin contact
20,809 posts in 4,355 threads, 1,447 registered users;
online 22 (1 registered, 21 guests [including 10 identified bots]).
Forum time: 14:09 CEST (Europe/Vienna)

Medical statistician: One who will not accept that Columbus discovered America…
because he said he was looking for India in the trial plan.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz